Fresenius Medical Care AG & Co. KGaA (FMS) Balance Sheet
FMS balance sheet, 2025
December 31, 2025 · euros€31.00B assets = €16.72B liabilities + €14.28B equity
Both columns are drawn to the same scale: what FMS owns equals what it owes plus shareholders’ equity. Hover a block for its value.
FMS financial health
Descriptive bands, not a rating. Fiscal 2025.
FMS balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | €25.50B2016 | €31.00B2025 | +2.2%/yr | |
| Total liabilities | €14.45B2016 | €16.72B2025 | +1.6%/yr | |
| Shareholders’ equity | €9.98B2016 | €14.28B2025 | +4.1%/yr | |
| Cash & short-term investments | €974.7M2016 | €1.60B2025 | +5.7%/yr | |
| Total debt | €8.13B2016 | €10.79B2025 | +3.2%/yr | |
| Net cash (debt) | −€7.16B2016 | −€9.20B2025 | −€2.0B | |
| Working capital | €1.59B2016 | €1.65B2025 | +€67.9M | |
| Current ratio | 1.302016 | 1.262025 | −0.03 | |
| Debt / equity | 0.822016 | 0.762025 | −0.06 | |
| Shares outstanding | 612.7M2016 | 582.4M2025 | −0.6%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
FMS assets
FMS liabilities and equity
FMS debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
FMS balance sheet in euros
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | €1.60B | €1.34B | €1.56B | €1.46B | €1.64B | €1.24B | €1.16B | €2.27B | €993.6M | €974.7M |
| Cash & equivalents | €1.60B | €1.18B | €1.40B | €1.27B | €1.48B | €1.08B | €1.01B | €2.15B | €978.1M | €708.9M |
| Short-term investments | €238.8M | €163.1M | €154.4M | €187.8M | €159.2M | €161.7M | €155.5M | €119.5M | €15.5M | €265.8M |
| Receivables | €3.14B | €3.41B | €3.64B | €3.72B | €3.58B | €3.62B | €3.59B | €3.43B | €3.50B | €3.70B |
| Inventory | €2.14B | €2.07B | €2.18B | €2.30B | €2.04B | €1.90B | €1.66B | €1.47B | €1.29B | €1.34B |
| Other current assets | €1.02B | €1.10B | €1.33B | €725.8M | €708.0M | €517.4M | €746.6M | €684.6M | €589.0M | €871.2M |
| Total current assets | €7.90B | €7.92B | €8.70B | €8.20B | €7.97B | €7.28B | €7.17B | €7.85B | €6.37B | €6.88B |
| Property, plant & equipment (net) | €3.01B | €7.26B | €7.45B | €8.34B | €8.55B | €4.13B | €8.52B | €3.84B | €3.49B | €3.58B |
| Goodwill & intangible assets | €28.40B | €16.54B | €16.01B | €17.31B | €15.82B | €14.34B | €15.44B | €12.89B | €12.79B | €13.80B |
| Long-term investments | €1.32B | €1.42B | €1.25B | €773.7M | €786.9M | €761.1M | €696.9M | €649.8M | €647.0M | €645.9M |
| Other non-current assets | €0 | €427.8M | €507.5M | €1.13B | €1.24B | €5.18B | €1.11B | €1.02B | €725.1M | €594.0M |
| Total assets | €31.00B | €33.57B | €33.93B | €35.75B | €34.37B | €31.69B | €32.93B | €26.24B | €24.03B | €25.50B |
| Liabilities | ||||||||||
| Accounts payable | €738.0M | €984.3M | €885.1M | €951.6M | €857.5M | €827.4M | €835.2M | €795.1M | €737.8M | €839.6M |
| Short-term debt | €2.20B | €1.22B | €1.56B | €2.02B | €2.59B | €1.70B | €3.26B | €2.50B | €1.65B | €1.30B |
| Deferred revenue | — | €82.2M | €85.8M | €105.7M | €518.0M | €606.3M | €30.9M | €68.2M | €275.1M | €218.1M |
| Total current liabilities | €6.25B | €5.66B | €6.11B | €6.47B | €7.26B | €6.16B | €7.06B | €6.27B | €5.30B | €5.30B |
| Long-term debt | €8.60B | €9.76B | €10.49B | €11.18B | €10.73B | €10.68B | €10.52B | €5.05B | €5.79B | €6.83B |
| Lease obligations | €3.49B | €4.14B | €4.15B | €4.68B | €4.75B | €4.49B | €4.71B | €0 | €0 | €0 |
| Other long-term liabilities | €1.88B | €2.38B | €2.50B | €2.66B | €2.40B | €2.51B | €2.12B | €2.03B | €2.10B | €2.32B |
| Total liabilities | €16.72B | €17.80B | €19.10B | €20.30B | €20.39B | €19.36B | €19.71B | €13.34B | €13.20B | €14.45B |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | €14.28B | €293.4M | €293.4M | €293.4M | €293.0M | €292.9M | €304.4M | €307.9M | €308.1M | €360.9M |
| Retained earnings (deficit) | €12.21B | €11.27B | €10.92B | €10.71B | €10.83B | €10.25B | €9.45B | €8.83B | €7.14B | €8.40B |
| Treasury stock | — | — | — | — | — | — | −€370.5M | −€51.0M | −€108.9M | −€51.0M |
| Accumulated other comprehensive income | — | −€328.5M | −€975.2M | −€388.5M | −€1.31B | −€2.21B | −€1.04B | −€1.20B | −€1.49B | −€1.25B |
| Minority interest | €973.0M | €1.19B | €1.21B | €1.46B | — | — | €0 | €0 | €0 | €0 |
| Total shareholders' equity | €14.28B | €14.58B | €13.62B | €13.99B | €12.70B | €12.33B | €11.96B | €11.76B | €9.82B | €9.98B |
| Key figures | ||||||||||
| Total debt | €10.79B | €11.00B | €12.08B | €13.21B | €13.32B | €12.38B | €13.82B | €7.58B | €7.52B | €8.13B |
| Net cash (debt) | −€9.20B | −€9.66B | −€10.52B | −€11.75B | −€11.68B | −€11.14B | −€12.66B | −€5.31B | −€6.53B | −€7.16B |
| Working capital | €1.65B | €2.26B | €2.59B | €1.74B | €709.6M | €1.11B | €106.1M | €1.58B | €1.07B | €1.59B |
| Tangible book value | −€14.11B | −€1.96B | −€2.39B | −€3.32B | −€3.12B | −€2.01B | −€3.49B | −€1.13B | −€2.97B | −€3.82B |
| Shares outstanding | 582.4M | 586.8M | 586.8M | 586.5M | 586.1M | 294.3M | 588.6M | 614.5M | 614.6M | 612.7M |
| Current ratio | 1.26 | 1.40 | 1.42 | 1.27 | 1.10 | 1.18 | 1.02 | 1.25 | 1.20 | 1.30 |
| Quick ratio | 0.76 | 0.84 | 0.85 | 0.80 | 0.72 | 0.79 | 0.67 | 0.91 | 0.85 | 0.88 |
| Debt / equity | 0.76 | 0.75 | 0.89 | 0.94 | 1.05 | 1.00 | 1.16 | 0.64 | 0.77 | 0.82 |
| Equity / assets | 46.1% | 43.4% | 40.1% | 39.1% | 37.0% | 38.9% | 36.3% | 44.8% | 40.9% | 39.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | €1.45B | €1.62B | €1.60B | €1.26B | €2.19B | €1.07B | €1.34B | €1.37B | €1.09B | €1.15B | €1.56B | €1.55B |
| Cash & equivalents | €1.06B | €1.24B | €1.60B | €1.26B | €1.72B | €1.07B | €1.18B | €1.37B | €1.09B | €1.15B | €1.40B | €1.55B |
| Short-term investments | €388.1M | €384.2M | €238.8M | €557.0M | €475.0M | €414.9M | €163.1M | €335.9M | €725.1M | €250.4M | €154.4M | — |
| Receivables | €3.47B | €3.72B | €3.14B | €3.28B | €3.23B | €3.59B | €3.41B | €3.28B | €4.06B | €4.05B | €3.64B | €3.71B |
| Inventory | €2.33B | €2.30B | €2.14B | €2.09B | €2.00B | €2.08B | €2.07B | €2.10B | €2.23B | €2.22B | €2.18B | €2.30B |
| Other current assets | €442.9M | €466.2M | €1.02B | €1.21B | €718.3M | €1.22B | €1.10B | €1.34B | €1.31B | €1.87B | €1.33B | €1.48B |
| Total current assets | €7.69B | €8.11B | €7.90B | €7.82B | €8.14B | €7.96B | €7.92B | €8.09B | €8.69B | €9.28B | €8.70B | €9.05B |
| Property, plant & equipment (net) | €6.43B | €6.44B | €3.01B | €6.40B | €6.50B | €6.98B | €7.26B | €6.98B | €7.26B | €7.31B | €7.45B | €7.89B |
| Goodwill & intangible assets | €15.25B | €15.10B | €28.40B | €14.84B | €14.87B | €15.97B | €16.54B | €15.54B | €16.16B | €16.04B | €16.01B | €16.81B |
| Long-term investments | €1.36B | €1.33B | €1.32B | €1.36B | €1.34B | €1.35B | €1.42B | €1.48B | €0 | €1.31B | €1.25B | €705.1M |
| Other non-current assets | €570.1M | €482.9M | €0 | €465.5M | €444.4M | €474.4M | €427.8M | €432.2M | €1.78B | €406.1M | €507.5M | €1.18B |
| Total assets | €31.29B | €31.47B | €31.00B | €30.89B | €31.29B | €32.74B | €33.57B | €32.51B | €33.90B | €34.34B | €33.93B | €35.63B |
| Liabilities | ||||||||||||
| Accounts payable | €891.8M | €890.4M | €738.0M | €827.0M | €751.7M | €895.9M | €984.3M | €772.0M | €784.0M | €835.4M | €885.1M | €844.8M |
| Short-term debt | €2.33B | €2.39B | €2.20B | €1.14B | €1.60B | €1.31B | €1.22B | €1.65B | €1.42B | €1.52B | €1.56B | €1.91B |
| Deferred revenue | — | — | — | — | — | — | €82.2M | — | €139.4M | −€1.52B | €85.8M | €222.8M |
| Total current liabilities | €7.18B | €6.73B | €6.25B | €5.76B | €5.66B | €5.45B | €5.66B | €5.89B | €5.94B | €6.20B | €6.11B | €6.62B |
| Long-term debt | €5.82B | €5.74B | €8.60B | €9.34B | €9.42B | €9.51B | €9.76B | €9.56B | €6.85B | €7.02B | €6.96B | €11.07B |
| Lease obligations | €3.40B | €3.49B | €3.49B | €3.61B | €3.68B | €3.99B | €4.14B | €3.92B | €4.10B | €4.11B | €4.15B | €4.45B |
| Other long-term liabilities | €4.76B | €4.79B | €1.88B | €1.88B | €1.88B | €2.28B | €2.38B | €2.27B | €5.92B | €5.98B | €6.03B | €2.51B |
| Total liabilities | €17.76B | €17.26B | €16.72B | €16.98B | €16.96B | €17.23B | €17.80B | €17.72B | €18.71B | €19.20B | €19.10B | €20.20B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | €268.6M | €293.4M | €14.28B | €293.4M | €293.4M | €293.4M | €293.4M | €293.4M | €293.4M | €293.4M | €293.4M | €293.4M |
| Retained earnings (deficit) | €12.09B | €12.30B | €12.21B | €11.84B | €11.29B | €11.47B | €11.27B | €11.09B | €10.87B | €11.03B | €10.92B | €10.76B |
| Accumulated other comprehensive income | −€1.31B | −€1.44B | — | −€1.67B | −€1.66B | −€741.3M | −€328.5M | −€1.14B | −€620.5M | −€798.8M | −€975.2M | −€424.1M |
| Minority interest | €974.5M | €962.9M | €973.0M | €959.6M | €1.06B | €1.13B | — | — | — | — | — | — |
| Total shareholders' equity | €12.56B | €13.24B | €14.28B | €12.95B | €13.27B | €14.37B | €14.58B | €13.62B | €13.93B | €13.91B | €13.62B | €14.01B |
| Key figures | ||||||||||||
| Total debt | €10.96B | €11.03B | €10.79B | €10.47B | €11.02B | €10.84B | €11.00B | €11.23B | €11.78B | €12.06B | €12.08B | €12.97B |
| Net cash (debt) | −€9.51B | −€9.41B | −€9.20B | −€9.22B | −€8.83B | −€9.77B | −€9.66B | −€9.86B | −€10.69B | −€10.91B | −€10.52B | −€11.42B |
| Working capital | €511.7M | €1.38B | €1.65B | €2.06B | €2.48B | €2.51B | €2.26B | €2.20B | €2.75B | €3.08B | €2.59B | €2.43B |
| Tangible book value | −€2.69B | −€1.86B | −€14.11B | −€1.89B | −€1.60B | −€1.60B | −€1.96B | −€1.91B | −€2.23B | −€2.13B | −€2.39B | −€2.81B |
| Shares outstanding | 539.2M | 550.4M | 571.8M | 584.7M | 586.8M | 586.8M | 586.8M | 586.8M | 586.8M | 586.8M | 879.9M | 879.9M |
| Current ratio | 1.07 | 1.20 | 1.26 | 1.36 | 1.44 | 1.46 | 1.40 | 1.37 | 1.46 | 1.50 | 1.42 | 1.37 |
| Quick ratio | 0.68 | 0.79 | 0.76 | 0.79 | 0.96 | 0.86 | 0.84 | 0.79 | 0.87 | 0.84 | 0.85 | 0.80 |
| Debt / equity | 0.87 | 0.83 | 0.76 | 0.81 | 0.83 | 0.75 | 0.75 | 0.82 | 0.85 | 0.87 | 0.89 | 0.93 |
| Equity / assets | 40.1% | 42.1% | 46.1% | 41.9% | 42.4% | 43.9% | 43.4% | 41.9% | 41.1% | 40.5% | 40.1% | 39.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in euros as reported (latest annual report filed February 24, 2026); data from EODHD.
FMS financial position
At the end of fiscal 2025 (December 31, 2025), Fresenius Medical Care AG & Co. KGaA had total assets of €31.0 billion (down 7.6% from a year earlier), total liabilities of €16.7 billion and shareholders' equity of €14.3 billion. It held €1.6 billion in cash and short-term investments against €10.8 billion of debt, net debt of €9.2 billion. Its current ratio was 1.26. In the latest quarter (ended June 30, 2026) total assets were €31.3 billion and equity €12.6 billion.
Related: FMS income statement, FMS cash flow statement, FMS key metrics. See the FMS stock overview for the latest quote and news.
FMS balance sheet FAQ
What are Fresenius Medical Care AG & Co. KGaA's total assets?
Fresenius Medical Care AG & Co. KGaA reported total assets of €31.0 billion at the end of fiscal 2025 (December 31, 2025), compared with €33.6 billion a year earlier.
How much debt does Fresenius Medical Care AG & Co. KGaA have?
Fresenius Medical Care AG & Co. KGaA had €10.8 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.76.
How much cash does Fresenius Medical Care AG & Co. KGaA have?
Fresenius Medical Care AG & Co. KGaA held €1.6 billion in cash and short-term investments at the end of fiscal 2025; with €10.8 billion of debt that is net debt of €9.2 billion.
What is Fresenius Medical Care AG & Co. KGaA's book value?
Fresenius Medical Care AG & Co. KGaA's shareholders' equity (book value) was €14.3 billion at the end of fiscal 2025.
What is Fresenius Medical Care AG & Co. KGaA's current ratio?
Fresenius Medical Care AG & Co. KGaA had current assets of €7.9 billion and current liabilities of €6.2 billion, a current ratio of 1.26 (it can cover its short-term obligations).
How much goodwill does Fresenius Medical Care AG & Co. KGaA have?
Fresenius Medical Care AG & Co. KGaA carried €28.4 billion of goodwill and intangible assets, 91.6% of total assets, at the end of fiscal 2025.